Skip to main content
Top
Published in: Acta Diabetologica 1/2009

01-03-2009 | Original Article

Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes

Authors: D. A. Chistiakov, V. A. Potapov, D. C. Khodirev, M. S. Shamkhalova, M. V. Shestakova, V. V. Nosikov

Published in: Acta Diabetologica | Issue 1/2009

Login to get access

Abstract

The KCNJ11 and ABCC8 genes encode the components of the pancreatic ATP-sensitive potassium (KATP) channel, which regulates insulin secretion by β-cells and hence could be involved in the pathogenesis of type 2 diabetes (T2D). The KCNJ11 E23K and ABCC8 exon 31 variants have been studied in 127 Russian T2D patients and 117 controls using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) approach. The KCNJ11 E23 variant and the ABCC8 exon 31 allele A were associated with higher risk of T2D [Odds ratio (OR) of 1.53 (= 0.023) and 2.41 (= 1.95 × 10−5)], respectively. Diabetic carriers of the ABCC8 G/G variant had reduced 2 h glucose compared to A/A + A/G (= 0.031). The G/G genotype of ABCC8 was also significantly associated with increased both fasting and 2 h serum insulin in diabetic and non-diabetic patients. A HOMA-β value characterizing the β-cell homeostasis was higher in the non-diabetic carriers homozygous for G/G (98.0 ± 46.9) then for other genotypes (HOMA-β = 85.6 ± 45.5 for A/A + A/G, = 0.0015). The KCNJ11 E23K and ABCC8 exon 31 variants contribute to susceptibility to T2D diabetes, glucose intolerance and altered insulin secretion in a Russian population.
Literature
1.
go back to reference Seino S, Miki T (2003) Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 8:133–176CrossRef Seino S, Miki T (2003) Physiological and pathophysiological roles of ATP-sensitive K+ channels. Prog Biophys Mol Biol 8:133–176CrossRef
2.
go back to reference Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135PubMedCrossRef Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135PubMedCrossRef
3.
go back to reference Smith AJ, Taneja TK, Mankouri J, Sivaprasadao A (2007) Molecular cell biology of KATP channels: implications for neonatal diabetes. Expert Rev Mol Med 9:1–17PubMedCrossRef Smith AJ, Taneja TK, Mankouri J, Sivaprasadao A (2007) Molecular cell biology of KATP channels: implications for neonatal diabetes. Expert Rev Mol Med 9:1–17PubMedCrossRef
4.
go back to reference Nichols CG, Koster JC, Remedi MS (2007) β-cell hyperexcitability: from hyperinsulinism to diabetes. Diabetes Obes Metab 9:81–88PubMedCrossRef Nichols CG, Koster JC, Remedi MS (2007) β-cell hyperexcitability: from hyperinsulinism to diabetes. Diabetes Obes Metab 9:81–88PubMedCrossRef
5.
go back to reference Schwanstecher C, Meyer U, Schwanstecher M (2002) KIR6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic β-cell ATP-sensitive K channels. Diabetes 51:875–879PubMedCrossRef Schwanstecher C, Meyer U, Schwanstecher M (2002) KIR6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic β-cell ATP-sensitive K channels. Diabetes 51:875–879PubMedCrossRef
6.
go back to reference Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P (1998) Missense mutations of the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 41:1511–1515PubMedCrossRef Hani EH, Boutin P, Durand E, Inoue H, Permutt MA, Velho G, Froguel P (1998) Missense mutations of the pancreatic islet beta cell inwardly rectifying K+ channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia 41:1511–1515PubMedCrossRef
7.
go back to reference Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC (2003) Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 18:206–212CrossRef Gloyn AL, Hashim Y, Ashcroft SJ, Ashfield R, Wiltshire S, Turner RC (2003) Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53). Diabet Med 18:206–212CrossRef
8.
go back to reference Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, levy JC, Sampson M, Halford S, McCarthy MI, Hatterlsey AT, Frayling TM (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568–572PubMedCrossRef Gloyn AL, Weedon MN, Owen KR, Turner MJ, Knight BA, Hitman G, Walker M, levy JC, Sampson M, Halford S, McCarthy MI, Hatterlsey AT, Frayling TM (2003) Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52:568–572PubMedCrossRef
9.
go back to reference Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Altshuler D (2007) Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 56:531–536PubMedCrossRef Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Altshuler D (2007) Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 56:531–536PubMedCrossRef
10.
go back to reference Sakamoto Y, Inoue H, Keshavarz P, Miyawaki K, Yamaguchi Y, Moritani M, Kunika K, Nakamura N, Yoshikawa T, Yasui N, Shiota H, Tanahashi T, Itakura M (2007) SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet 52:781–793PubMedCrossRef Sakamoto Y, Inoue H, Keshavarz P, Miyawaki K, Yamaguchi Y, Moritani M, Kunika K, Nakamura N, Yoshikawa T, Yasui N, Shiota H, Tanahashi T, Itakura M (2007) SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. J Hum Genet 52:781–793PubMedCrossRef
11.
go back to reference Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y (2007) Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama Study. Diabetes 56:2829–2833PubMedCrossRef Doi Y, Kubo M, Ninomiya T, Yonemoto K, Iwase M, Arima H, Hata J, Tanizaki Y, Iida M, Kiyohara Y (2007) Impact of Kir6.2 E23K polymorphism on the development of type 2 diabetes in a general Japanese population: the Hisayama Study. Diabetes 56:2829–2833PubMedCrossRef
12.
go back to reference Shaat N, Ekelund M, Lernmark A, Ivarsson S, Almgren P, Berntorp K, Groop L (2005) Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia 48:2544–2551PubMedCrossRef Shaat N, Ekelund M, Lernmark A, Ivarsson S, Almgren P, Berntorp K, Groop L (2005) Association of the E23K polymorphism in the KCNJ11 gene with gestational diabetes mellitus. Diabetologia 48:2544–2551PubMedCrossRef
13.
go back to reference Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glumer C, Thorsteinsson B, Borch-Johnsen K, Hansen T, Pedersen O (2003) The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52:573–577PubMedCrossRef Nielsen EM, Hansen L, Carstensen B, Echwald SM, Drivsholm T, Glumer C, Thorsteinsson B, Borch-Johnsen K, Hansen T, Pedersen O (2003) The E23K variant of Kir6.2 associates with impaired post-OGTT serum insulin response and increased risk of type 2 diabetes. Diabetes 52:573–577PubMedCrossRef
14.
go back to reference Florez JC, Burtt N, de Bakker PIW, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ, Schaffner SF, Daly MJ, Hirschhorn JN, Groop L, Altshuler D (2004) Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53:1360–1368PubMedCrossRef Florez JC, Burtt N, de Bakker PIW, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ, Schaffner SF, Daly MJ, Hirschhorn JN, Groop L, Altshuler D (2004) Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 53:1360–1368PubMedCrossRef
15.
go back to reference Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, Tuomi T, Groop L (2005) The Botnia Study Group: genetic prediction of future type 2 diabetes. PLoS Med 2:e345PubMedCrossRef Lyssenko V, Almgren P, Anevski D, Orho-Melander M, Sjogren M, Saloranta C, Tuomi T, Groop L (2005) The Botnia Study Group: genetic prediction of future type 2 diabetes. PLoS Med 2:e345PubMedCrossRef
16.
go back to reference van Dam RM, Hoebee B, Seidell JC, Schaap MM, de Bruin TWA, Feskens EJM (2005) Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med 22:590–598PubMedCrossRef van Dam RM, Hoebee B, Seidell JC, Schaap MM, de Bruin TWA, Feskens EJM (2005) Common variants in the ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies and meta-analyses. Diabet Med 22:590–598PubMedCrossRef
17.
go back to reference Laukkanen O, Pihlajamaki J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kuikaanniemi S, Tuomilehto J, Uusitupa M, Laakso M (2004) Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) Genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89:6286–6290PubMedCrossRef Laukkanen O, Pihlajamaki J, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kuikaanniemi S, Tuomilehto J, Uusitupa M, Laakso M (2004) Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) Genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. J Clin Endocrinol Metab 89:6286–6290PubMedCrossRef
18.
go back to reference Riedel MJ, Light PE (2005) Saturated and cis/trans unsaturated acyl CoA esters differentially regulate wild-type and polymorphic β-cell ATP-sensitive K+ channels. Diabetes 54:2070–2079PubMedCrossRef Riedel MJ, Light PE (2005) Saturated and cis/trans unsaturated acyl CoA esters differentially regulate wild-type and polymorphic β-cell ATP-sensitive K+ channels. Diabetes 54:2070–2079PubMedCrossRef
19.
go back to reference Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J (2000) Sur1 knockout mice: a model for KATP channel-independent regulation of insulin secretion. J Biol Chem 275:9270–9277PubMedCrossRef Seghers V, Nakazaki M, DeMayo F, Aguilar-Bryan L, Bryan J (2000) Sur1 knockout mice: a model for KATP channel-independent regulation of insulin secretion. J Biol Chem 275:9270–9277PubMedCrossRef
20.
go back to reference Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA (2002) Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 277:37176–37183PubMedCrossRef Shiota C, Larsson O, Shelton KD, Shiota M, Efanov AM, Hoy M, Lindner J, Kooptiwut S, Juntti-Berggren L, Gromada J, Berggren PO, Magnuson MA (2002) Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J Biol Chem 277:37176–37183PubMedCrossRef
21.
go back to reference Doliba NM, Qin W, Vatamaniuk MZ, Li C, Zelent D, Hajafi H, Buettger CW, Collins HW, Carr RD, Magnuson MA, Matschinsky FM (2004) Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. Am J Physiol Endocrinol Metab 286:E834–E843PubMedCrossRef Doliba NM, Qin W, Vatamaniuk MZ, Li C, Zelent D, Hajafi H, Buettger CW, Collins HW, Carr RD, Magnuson MA, Matschinsky FM (2004) Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. Am J Physiol Endocrinol Metab 286:E834–E843PubMedCrossRef
22.
go back to reference Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80PubMedCrossRef Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76–80PubMedCrossRef
23.
go back to reference Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Mykkanen L, Kuusisto J, Karhapaa P, Laakso M (2000) Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23:70–73PubMedCrossRef Rissanen J, Markkanen A, Karkkainen P, Pihlajamaki J, Mykkanen L, Kuusisto J, Karhapaa P, Laakso M (2000) Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 23:70–73PubMedCrossRef
24.
go back to reference Hansen T, Ambye L, Grarup N, hansen L, Echward SM, Ferrer J, Pedersen O (2001) Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Diabetologia 44:1330–1334PubMedCrossRef Hansen T, Ambye L, Grarup N, hansen L, Echward SM, Ferrer J, Pedersen O (2001) Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus. Diabetologia 44:1330–1334PubMedCrossRef
25.
go back to reference Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ (2001) Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1 alpha genes. Diabetes Care 24:472–478PubMedCrossRef Elbein SC, Sun J, Scroggin E, Teng K, Hasstedt SJ (2001) Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1 alpha genes. Diabetes Care 24:472–478PubMedCrossRef
26.
go back to reference Hart LM, Dekker JM, van Haeften TW, Ruige JB, Stehouwer CD, Erkelens DW, Heine RJ, Maassen JA (2000) Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus. Diabetologia 43:515–519PubMedCrossRef Hart LM, Dekker JM, van Haeften TW, Ruige JB, Stehouwer CD, Erkelens DW, Heine RJ, Maassen JA (2000) Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus. Diabetologia 43:515–519PubMedCrossRef
27.
go back to reference Barroso I, Luan J, Middelberg RPS, Harding AH, Franks PW, Jakes PW, Clayton D, Schafer AJ, O’Rahilly S, Wareham NJ (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol 1:41–55CrossRef Barroso I, Luan J, Middelberg RPS, Harding AH, Franks PW, Jakes PW, Clayton D, Schafer AJ, O’Rahilly S, Wareham NJ (2003) Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol 1:41–55CrossRef
28.
go back to reference Reis AF, Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G (2000) Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 107:138–144PubMedCrossRef Reis AF, Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G (2000) Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Hum Genet 107:138–144PubMedCrossRef
29.
go back to reference Goksel DL, Fischbach K, Duggirala R, Mitchell BD, Aguilar-Bryan L, Blangero J, Stern MP, O’Connell P (1998) Variant in sulfonylurea re ceptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR1 gene variant and hyperinsulinemia. Hum Genet 103:280–285PubMedCrossRef Goksel DL, Fischbach K, Duggirala R, Mitchell BD, Aguilar-Bryan L, Blangero J, Stern MP, O’Connell P (1998) Variant in sulfonylurea re ceptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR1 gene variant and hyperinsulinemia. Hum Genet 103:280–285PubMedCrossRef
30.
go back to reference Kilpelainen TO, Lakka TA, Laaksonen DE, Laukkanen O, Lundstrom J, Eriksson JG, Valle TT, Hamalainen H, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M (2007) Laakso M (2007) Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31:264–272PubMedCrossRef Kilpelainen TO, Lakka TA, Laaksonen DE, Laukkanen O, Lundstrom J, Eriksson JG, Valle TT, Hamalainen H, Aunola S, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M (2007) Laakso M (2007) Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiol Genomics 31:264–272PubMedCrossRef
31.
go back to reference WHO (1985) Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 727:1–113 WHO (1985) Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 727:1–113
32.
go back to reference Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412–419PubMedCrossRef
34.
go back to reference Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J (2000) Use of the oral glucose tolerance test to access insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMedCrossRef Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen H, Van Haeften T, Renn W, Gerich J (2000) Use of the oral glucose tolerance test to access insulin release and insulin sensitivity. Diabetes Care 23:295–301PubMedCrossRef
35.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495PubMedCrossRef
36.
go back to reference Love-Gregory L, Wasson J, Lin J, Skolnick G, Suarez B, Permutt MA (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians as the PPARγ Pro12Ala variant. Diabetologia 46:136–137PubMed Love-Gregory L, Wasson J, Lin J, Skolnick G, Suarez B, Permutt MA (2003) E23K single nucleotide polymorphism in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians as the PPARγ Pro12Ala variant. Diabetologia 46:136–137PubMed
37.
go back to reference Tschritter O, Stimvoll M, Machicao F, Holzwarth M, Wiesser M, Maerker E, Teigeler A, Haring H, Fritsche A (2002) The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (Kir6.2) gene secretion is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes 51:3135–3138CrossRef Tschritter O, Stimvoll M, Machicao F, Holzwarth M, Wiesser M, Maerker E, Teigeler A, Haring H, Fritsche A (2002) The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (Kir6.2) gene secretion is associated with impaired glucagon suppression in response to hyperglycemia. Diabetes 51:3135–3138CrossRef
38.
go back to reference Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Kruppeit-Drews P, Aguilar-Bryan L (2007) ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Eur J Physiol 453:703–718CrossRef Bryan J, Munoz A, Zhang X, Dufer M, Drews G, Kruppeit-Drews P, Aguilar-Bryan L (2007) ABCC8 and ABCC9: ABC transporters that regulate K+ channels. Eur J Physiol 453:703–718CrossRef
Metadata
Title
Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes
Authors
D. A. Chistiakov
V. A. Potapov
D. C. Khodirev
M. S. Shamkhalova
M. V. Shestakova
V. V. Nosikov
Publication date
01-03-2009
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2009
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0056-5

Other articles of this Issue 1/2009

Acta Diabetologica 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.